THETFORD MINES, QUEBEC–(Marketwired – Jan. 30, 2015) – AlliancePharma Inc. (“Alliance” or the “Corporation”) (TSX VENTURE:APA) granted an aggregate of 375,000 stock options an exercise price of $0.15 per share for a period of 5 years (the “Options“) to certain directors, employees and consultants in accordance with the Corporation’s Stock Option Plan. The Option grant is subject to approval from the TSX Venture Exchange.
Pharmaceutical technology
Groupe KDA Inc © 2022. All Rights Reserved.